In line with the global trends, apart from creating HTA reports we plan and conduct primary and secondary studies, the aim of which is collecting credible cost and epidemiological data. The purpose of their results is to facilitate decision-making in the process of introducing new technologies to the market and negotiating the manner of their financing. In the last few years we have conducted numerous observational studies – both cross-sectional and longitudinal studies in several dozens of Polish hospitals, including registers and national studies. In order to save time and streamline access to data we use mobile solutions and use internet applications customised to particular projects.
prevalence of disease, characteristics of patients or types of care
of therapeutic pathways in clinical practice
and cost study (prospective and retrospective), used e.g. in risk sharing schemes